AKT1 and B-cell chronic lymphocytic leukemia: However, pharmacological inhibition of PI3K-mTOR/AKT signalling reduced FOXO1 phosphorylation, increased FOXO1 nuclear localisation and resulted in an upregulation of FOXO1-mediated genes, ultimately inducing CLL cell death (106).